Jul

5

2022

What is the prevalence of antiphospholipid antibodies in patients with systemic lupus erythematosus (SLE)?

By William Aird

A

What is the prevalence of antiphospholipid antibodies in patients with systemic lupus erythematosus (SLE)?

The prevalence of antiphospholipid antibodies among patients with SLE ranges from 15% to 34% for lupus anticoagulant, from 12% to 44% for anticardiolipin and from 10% to 19% for anti­β2‑glycoprotein 1 antibodies. Learn more here.

Stay Updated

If you are interested in getting the latest articles from The Blood Project, enter your name and email

  • This field is for validation purposes and should be left unchanged.